Joel Trugman

8PUBLICATIONS
21CO-AUTHORS
Autonomic nervous systemCharacterisation of biological macromoleculesPsychosocial aspects of childbirth and perinatal mental healthPainNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 28, 2026
Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans.

|Apr 21, 2026
Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial.

|Jun 02, 2025
Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study.

Ramesh R Boinpally, Jonathan H Smith, Rosa L De Abreu Ferreira

|Feb 21, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trials.

Peter J Goadsby, Tim P Jürgens, Elimor Brand-Schieber

|Oct 14, 2024
Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening Period.

Todd J Schwedt, Richard B Lipton, Peter J Goadsby

|Aug 28, 2024
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.

Richard B Lipton, Andrea M Harriott, Julia Y Ma

Pageof 2

Frequent Collaborators

6 joint publications

Ramesh R Boinpally

2 joint publications

Mohamad Shebley

2 joint publications

Richard B Lipton

2 joint publications

Jonathan H Smith